Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reissue Patent
2006-05-02
2006-05-02
Russel, Jeffrey Edwin (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S844000, C514S906000, C604S511000, C604S522000
Reissue Patent
active
RE039086
ABSTRACT:
This invention provides the use of Botulinum toxin (BTX) to cause paralysis of a depressor anguli oris (DAO) musculature in a patient to alleviate downturn at corners of the patient's mouth.
REFERENCES:
patent: 5401243 (1995-03-01), Borodic
patent: 5750141 (1998-05-01), Roberts et al.
patent: 6001088 (1999-12-01), Roberts et al.
Hoefflin (1998). “Anatomy of the Platysma and Lip Depressor Muscles”.Dermatol. Surg., vol. 24: 1225-1231.
Bikhazi et al. “Refinement in the Rehabilitation fop the Paralyzed Face . . . ” Otol. Head Neck Surg. vol. 117, No. 4, pp. 303-307, Oct. 1997.
Garcia et al. “Cosmetic Denervation of the Muscles . . . ” Dermatol. Surg. vol. 22, pp. 39-43, 1996.
Guyuron et al. “Aesthetic Indications for Botulinum . . . ” Plast. Reconstr. Surg. vol. 93, No. 5, pp. 913-918, Apr. 1994.
Song. “Botulinum Toxin Type A Injection . . . ” Annals Pharmacotherapy. vol. 32, pp. 1365-1367, Dec. 1998.
Wieder et al. “Understanding Botulinum Toxin” Dermatol. Surg. vol. 24, pp. 1172-1174, 1998.
Armstrong et al. (1996). “Treatment of facial synkinesis and facial asymmetry with botulinum toxin type A following facial nerve palsy” Clin. Otolaryngol., vol. 21: 15-20.
Brandt et al. (1998). “Cosmetic Use of Botulinum A exotoxin for the Aging Neck” Dermatol. Surg., vol. 24: 1232-1234.
Carruthers, (1999). “Botulinum Toxin for Midfacial Defects” 57th Annual Meeting American Academy of Dermatology, pp. 21-22.
Carruthers et al. (1998). “The Adjunctive Usage of Botulinum Toxin” Dermatol. Surg., vol. 24: 1244-1247.
Carruthers et al. (1998). “Clinical Indications and Injection Technique for the Cosmetic Use of Botulinum A Exotoxin” Dermatol. Surg. vol. 24: 1189-1194.
Carruthers et al. (1998). “History of the Cosmetic Use of Botulinum A Exotoxin” Dermatol. Surg. vol. 24: 1168-1170.
Carruthers et al. (1996). “Botulinum A exotoxin in clinical ophthalmology” Can. J. Ophthalmol., vol. 31(7): 389-400.
Carruthers et al. (1994). “Botulinum Toxin in the Treatment of Glabellar Frown Lines and Other Facial Wrinkles” In Therapy with Botulinum Toxin (Jankovic et al. eds.) Ch. 46: 577-595.
Klein (1999). “Botulinum Toxin for the Aging Face” 57th Annual Meeting American Academy of Dermatology, pp. 20-20C.
Sabbaugh, “Extending the use of botulinum toxin for aesthetic indications”,Eye World, 3(6):37-8, (Jun. 1998).
Blitzer et al., “Botulinum toxin for the treatment of hyperfunctional lines of the face”, Arch Otolaryngol-Head Neck Sug. Sep. 1993; 119(9):1018-22.
Foster, “Botulinum toxin can smooth out the wrinkles”, Ophthalmology Times, Apr., 1997.
Abstract—Klein, Using obtulinum toxin to treat facial and periocular wrinkles, Ocul Surg. News Oct. 1992:10(20):166-7.
Carruthers Alastair
Carruthers Jean D. A.
Allergan Inc.
Hollrigel Greg S.
Russel Jeffrey Edwin
Stout, Uxa Buyan & Mullins, LLP
Uxa Frank J.
LandOfFree
Cosmetic use of botulinum toxin for treatment of downturned... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cosmetic use of botulinum toxin for treatment of downturned..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cosmetic use of botulinum toxin for treatment of downturned... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3652426